Biodesix (BDSX) Total Non-Current Liabilities (2019 - 2026)

Biodesix (BDSX) has reported Total Non-Current Liabilities for 8 consecutive years, with $71.0 million the latest figure, recorded in Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $71.0 million, up 14.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $71.0 million (up 14.79% YoY), and the FY2025 annual result was $72.5 million, up 16.85% from the prior year.
• Total Non-Current Liabilities was $71.0 million for Q1 2026 at Biodesix, down from $72.5 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $72.5 million in Q4 2025 and troughed at $24.1 million in Q1 2022.
• Average Total Non-Current Liabilities over 5 years is $56.5 million, with a median of $61.5 million recorded in 2024.
• Year-over-year, Total Non-Current Liabilities tumbled 61.77% in 2022 and soared 125.05% in 2023.
• Over 5 years, Total Non-Current Liabilities stood at $49.5 million in 2022, then rose by 23.53% to $61.1 million in 2023, then rose by 1.56% to $62.1 million in 2024, then rose by 16.85% to $72.5 million in 2025, then declined by 2.05% to $71.0 million in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $71.0 million in Q1 2026, $72.5 million in Q4 2025, and $72.3 million in Q3 2025.